ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

AZTR Azitra Inc

0,1432
0,0008 (0,56%)
Après les heures de négociation
Dernière mise à jour : 22:11:05
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Azitra Inc AZTR AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,0008 0,56% 0,1432 22:11:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,148 0,133 0,158 0,136098 0,1424
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/6/202422:30EDGAR2Form DEF 14A - Other definitive proxy statements
31/5/202414:00BWAzitra, Inc. Announces Presentation at the 2024 BIO..
24/5/202422:55EDGAR2Form PRE 14A - Other preliminary proxy statements
17/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data from ATR-04..
10/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data of ATR-12..
09/5/202423:05EDGAR2Form 8-K - Current report
09/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202423:00BWAzitra, Inc. Announces Q1 2024 Financial Results and..
22/4/202422:30BWAzitra, Inc. Announces New Preclinical Data to be Presented..
18/4/202422:15BWAzitra, Inc. to Present New Data at Three Upcoming..
15/3/202421:15BWAzitra, Inc. Announces Full Year 2023 Financial Results and..
26/2/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/2/202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/2/202422:05BWAzitra, Inc. Announces Closing of Public Offering
16/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202415:15EDGAR2Form 8-K - Current report
14/2/202404:09BWAzitra, Inc. Announces Pricing of Public Offering
19/1/202417:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
19/1/202415:19EDGAR2Form S-1 - General form for registration of securities under..
16/1/202415:00BWAzitra, Inc. Strengthens Intellectual Property Portfolio..
03/1/202415:00BWAzitra, Inc. to Present at Biotech Showcase 2024 and the..
04/12/202322:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202322:30BWAzitra, Inc. Announces Third Quarter 2023 Financial Results..
16/10/202314:00BWAzitra to Present at the ThinkEquity Conference
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202314:00PRNUSAzitra to Present at the H.C. Wainwright 25th Annual Global..
14/8/202322:11EDGAR2Form 8-K - Current report
14/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05PRNUSAzitra, Inc. Announces Second Quarter 2023 Financial Results..
19/7/202322:05PRNUSAzitra Adds Biotech Leaders Barbara Ryan and John Schroer to..
11/7/202322:05EDGAR2Form 8-K - Current report
11/7/202322:05PRNUSAzitra, Inc. Appoints Travis Whitfill as Chief Operating..
07/7/202322:05EDGAR2Form 8-K - Current report
03/7/202321:04EDGAR2Form SC 13D - General statement of acquisition of beneficial..
29/6/202322:56EDGAR2Form 4/A - Statement of changes in beneficial ownership of..